Center for Scientific Review; Notice of Closed Meeting, 73783-73784 [2015-29939]
Download as PDF
<![CDATA[
Federal Register / Vol. 80, No. 227 / Wednesday, November 25, 2015 / Notices
enrollment penalty, and IRMAA
determinations.
Section 1871(c) of the Act requires
that we publish a list of all Medicare
manual instructions, interpretive rules,
statements of policy, and guidelines of
general applicability not issued as
regulations at least every 3 months in
the Federal Register.
II. Format for the Quarterly Issuance
Notices
This quarterly notice provides the
specific updates to the OCPM that have
occurred in the 3-month period. A
hyperlink to the available chapters on
the OMHA Web site is provided below.
The OMHA Web site contains the most
current, up-to-date chapters and
revisions to chapters, and will be
available earlier than we publish our
quarterly notice. We believe the OMHA
Web site list provides more timely
access to the current OCPM chapters for
those involved in the Medicare claim,
organization and coverage
determination and entitlement appeals
processes. We also believe the Web site
offers the public a more convenient tool
for real time access to current OCPM
provisions. In addition, OMHA has a
listserv to which the public can
subscribe to receive immediate
notification of any updates to the
OMHA Web site. This listserv avoids
the need to check the OMHA Web site,
as update notifications are sent to
subscribers as they occur. If accessing
the OMHA Web site proves to be
difficult, the contact person listed above
can provide the information.
III. How To Use the Notice
This notice lists the OCPM chapters
and subjects published during the
quarter covered by the notice so the
reader may determine whether any are
of particular interest. We expect this
notice to be used in concert with the
previously published notice. The OCPM
can be accessed at https://www.hhs.gov/
omha/OMHA_Case_Processing_
Manual/.
tkelley on DSK3SPTVN1PROD with NOTICES
IV. OCPM Releases for July Through
September 2015
The OCPM is used by OMHA
adjudicators and staff to administer the
OMHA program. It offers day-to-day
operating instructions, policies, and
procedures based on statutes and
regulations, and OMHA directives.
The following is a list and description
of new and revised OCPM provisions,
and the subject matter, that have been
released in the covered 3-month period.
The full text of current OCPM
provisions is available on our Web site
VerDate Sep<11>2014
19:15 Nov 24, 2015
Jkt 238001
at https://www.hhs.gov/omha/OMHA_
Case_Processing_Manual/.
OCPM Division I: General Matters
Chapter 4, Parties. This new chapter
describes who qualify as parties to the
ALJ hearing and review process under
the applicable authorities to guide
OMHA ALJs and support staff in
ensuring those filing requests for
hearing and requests for review with
OMHA have standing to pursue appeals,
and notices and other correspondence
are sent to the appropriate individuals
and entities in accordance with the
authorities.
Chapter 5, Representatives. This new
chapter describes the roles and
responsibilities of party representatives
in the ALJ hearing and review process,
as well as the requirements to
substantiate that an individual is
authorized or appointed to act as a party
representative under the applicable
authorities.
Chapter 6, CMS and CMS Contractor
Roles. This new chapter describes the
roles and responsibilities of CMS and its
contractors in the ALJ hearing and
review process, including under what
conditions and how CMS or a contractor
may participate in the process,
including at oral hearings before OMHA
ALJs, in accordance with the applicable
authorities.
OCPM Division II: Part A/B Claim
Determinations
73783
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Mental Health Special Emphasis Panel AIDS
Research Centers on Mental Health and HIV/
AIDS (P30).
Date: December 2, 2015.
Time: 12:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852, (Telephone
Conference Call).
Contact Person: David W. Miller, Ph.D.,
Scientific Review Officer, Division of
Extramural Activities, National Institute of
Mental Health, NIH, Neuroscience Center,
6001 Executive BLVD, Room 6140, MSC
9608, Bethesda, MD 20892–9608, 301–443–
9734, millerda@mail.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program No. 93.242, Mental Health Research
Grants, National Institutes of Health, HHS)
Dated: November 18, 2015.
Carolyn A. Baum,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2015–29942 Filed 11–24–15; 8:45 am]
BILLING CODE 4140–01–P
Chapter 3, Procedural Screening. This
chapter has been updated to correct a
typographical error. No substantive
changes were made to the chapter.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Dated: _November 17, 2015.
Nancy J. Griswold,
Chief Administrative Law Judge, Office of
Medicare Hearings and Appeals.
Center for Scientific Review; Notice of
Closed Meeting
[FR Doc. 2015–30044 Filed 11–24–15; 8:45 am]
BILLING CODE 4152–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Mental Health;
Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
PO 00000
Frm 00086
Fmt 4703
Sfmt 4703
National Institutes of Health
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel;
Pathogenesis of Rare Diseases.
Date: November 20, 2015–November 20,
2016.
Time: 2:00 p.m. to 4:00 p.m.
E:\FR\FM\25NON1.SGM
25NON1
73784
Federal Register / Vol. 80, No. 227 / Wednesday, November 25, 2015 / Notices
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Richard Panniers, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2212,
MSC 7890, Bethesda, MD 20892, (301) 435–
1741, pannierr@csr.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: November 19, 2015.
Carolyn Baum,
Program Analyst, Office of Federal Advisory
Committee Policy.
Room 3170B, Research Triangle Park, NC
27709, 919/541–7556.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.115, Biometry and Risk
Estimation—Health Risks from
Environmental Exposures; 93.142, NIEHS
Hazardous Waste Worker Health and Safety
Training; 93.143, NIEHS Superfund
Hazardous Substances—Basic Research and
Education; 93.894, Resources and Manpower
Development in the Environmental Health
Sciences; 93.113, Biological Response to
Environmental Health Hazards; 93.114,
Applied Toxicological Research and Testing,
National Institutes of Health, HHS)
Center for Scientific Review; Notice of
Closed Meeting
tkelley on DSK3SPTVN1PROD with NOTICES
Name of Committee: National Institute of
Environmental Health Sciences Special
Emphasis Panel, Exposure to Water
Disinfection Byproducts.
Date: December 9, 2015.
Time: 1:00 p.m. to 2:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: NIEHS/National Institutes of Health,
Keystone Building, 530 Davis Drive, Room
3170B, Research Triangle Park, NC 27709,
(Telephone Conference Call).
Contact Person: Janice B. Allen, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, Division of Extramural Research and
Training, Nat. Institute of Environmental
Health Science, P.O. Box 12233, MD EC–30/
VerDate Sep<11>2014
19:15 Nov 24, 2015
Jkt 238001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
BILLING CODE 4140–01–P
National Institutes of Health
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
BILLING CODE 4140–01–P
[FR Doc. 2015–29943 Filed 11–24–15; 8:45 am]
BILLING CODE 4140–01–P
National Institute of Environmental
Health Sciences; Notice of Closed
Meeting
[FR Doc. 2015–30015 Filed 11–24–15; 8:45 am]
National Institutes of Health
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Dated: November 20, 2015.
Anna Snouffer,
Deputy Director, Office of Federal Advisory
Committee Policy.
Dated: November 18, 2015.
Carolyn Baum,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2015–29939 Filed 11–24–15; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
93.846– 93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Topics in
Virology.
Date: December 8, 2015.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892.
Contact Person: Richard G. Kostriken,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3192,
MSC 7808, Bethesda, MD 20892, 240–519–
7808, kostrikr@csr.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
PO 00000
Frm 00087
Fmt 4703
Sfmt 9990
Center for Scientific Review; Notice of
Closed Meeting
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Sleep,
Psychopathology, Emotion, and Stress.
Date: December 15, 2015.
Time: 1:00 p.m. to 2:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Andrea B Kelly, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3182,
MSC 7770, Bethesda, MD 20892, (301) 455–
1761, kellya2@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: November 20, 2015.
Anna Snouffer,
Deputy Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2015–30014 Filed 11–24–15; 8:45 am]
BILLING CODE 4140–01–P
E:\FR\FM\25NON1.SGM
25NON1
]]>Agencies
[Federal Register Volume 80, Number 227 (Wednesday, November 25, 2015)]
[Notices]
[Pages 73783-73784]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-29939]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Pathogenesis of Rare Diseases.
Date: November 20, 2015-November 20, 2016.
Time: 2:00 p.m. to 4:00 p.m.
[[Page 73784]]
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892, (Telephone Conference Call).
Contact Person: Richard Panniers, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2212, MSC 7890, Bethesda, MD
20892, (301) 435-1741, pannierr@csr.nih.gov.
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance Program Nos. 93.306,
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893,
National Institutes of Health, HHS)
Dated: November 19, 2015.
Carolyn Baum,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2015-29939 Filed 11-24-15; 8:45 am]
BILLING CODE 4140-01-P
